Abstract
Successful cell proliferation relies on the activation of genes involved in cell cycle progression and concurrent inhibition of the function of tumor suppressor genes. In addition, there is a need to maintain the viability in proliferating cells. In the absence of cell viability factors cell cycle progression is intrinsically linked to programmed cell death through apoptosis. Whereas much attention has been focused on the molecular description of cell cycle machinery and the apoptotic pathway, less attention has been paid to the mechanisms for maintenance of the cell viability while cells are progressing through the cell cycle. The interaction of mitogenic cytokines with their cognate receptors promotes entry to the S-phase of cell cycle. It has also been suggested that cytokines could directly provide cell survival signals based on the observations that cytokine withdrawal leads to apoptosis. However, it is not clear whether the mitogenic activities and the survival effects of these cytokines are exerted by a single biochemical mechanism or carried out through separate signaling pathways. It is, thus, important to establish whether the survival effects of cytokines are achieved directly or by synergizing with the action of survival factors present in the environment such as interstitial fluid or blood in vivo or culture medium in vitro. We have addressed this question by stimulating cells with cytokines in the presence or absence of exogenous serum in vitro. When incubated with cytokines in serum-free medium, several cell types underwent apoptosis, a phenomenon called cytokine-promoted apoptosis. Interestingly, we found that serum is the principle activator of the cell survival gene, Bcl-2; while mitogenic cytokines increase the expression of Bax. In this review, we discuss the relevance of cytokine-promoted apoptosis to the maintenance of cellular homeostasis during development and tumorigenesis.
Apoptosis, the main mechanism of programmed cell death, is a gene-directed process responsible for the elimination of excessive cells during development and detrimental cell types in pathophysiological situations (Wyllie et al., 1980). Aberrant apoptosis has been implicated in the etiology of cancer and the process of autoimmunity (Hale et al., 1996). It is also involved in the progression of some degenerative diseases as well as the evolution of drug resistance in tumors (Hickman, 1992). Deregulated expression of genes such as Bcl-2, loss of p53 expression, and autocrine activation of either apoptotic or antiapoptotic signal transduction pathways may all contribute to pathological apoptosis (McConkey et al., 1996).
Cell proliferation requires the modulation of at least two sets of genes: those that activate mitosis and those that maintain cell survival. The modulation of these genes is required to terminate cell cycle brakes, to activate cell cycle machinery, and to promote cell survival (Meikrantz and Schlegel, 1995). Much is known about the mechanisms of cell cycle promotion, the signals that regulate cell viability during cell cycle are yet to be determined.
Protooncogenes and tumor suppressor genes control and regulate cell cycle progression. In addition, both oncogenes and tumor suppressor genes play fundamental roles in the regulation of the pathways leading to programmed cell death (Chiarugi and Ruggiero, 1996). We have shown that the protooncogene c-Myc is required for activation-induced apoptosis in T cell hybridomas (Shi et al., 1992). Ectopic expression of Myc enhances cell cycle progression and, at the same time, promotes apoptosis of the cycling cells (Evan et al., 1992; Askew et al., 1993). It has also been shown that cyclin A and the CDK kinase inhibitor, p27, play fundamental roles in anti-IgM-induced apoptosis in B-cell lymphomas (Ezhevsky et al., 1996). This strongly suggests that cell cycle progression and apoptosis are tightly correlated, a notion which could have important implications in the understanding of the basic mechanisms regulating apoptosis. In this review, we explore the relationship between apoptosis and cell cycle progression by focusing on the recent studies in cytokine-promoted apoptosis, which will be important for the elucidation of the mechanisms by which normal cells manage to proliferate, and transformed cells undergo aberrant growth during tumorigenesis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alitalo, K., and Schwab, M. (1986). Oncogene amplification in tumor cells. Adv Cancer Res 47, 235–281.
Askew, D.S., Ihle, J.N., and Cleveland, J.L. (1993). Activation of apoptosis associated with enforced Myc expression in myeloid progenitor cells is dominant to the suppression of apoptosis by interleukin-3 or erythropoietin. Blood 82, 2079–2087.
Blandino, G., Scardigli, R., Rizzo, M.G., Crescenzi, M., Soddu, S., and Sacchi, A. (1995). Wild-type p53 modulates apoptosis of normal, IL-3 deprived, hematopoietic cells. Oncogene 10, 731–737.
Borset, M., Medvedev, A.E., Sundan, A., and Espevik T. (1996). The role of the two TNF receptors in proliferation, NF-kappa B activation and discrimination between TNF and LT alpha signalling in the human myeloma cell line OH-2. Cytokine 8, 430–438.
Branch, D.R., and Guilbert, L.J. (1996). Autocrine regulation of macrophage proliferation by tumor necrosis factor-alpha. Exp. Hematol. 24, 675–681.
Chiarugi, V., and Ruggiero, M. (1996). Role of three cancer “master genes” p53, Bell and c-Myc on the apoptotic process. Tumori. 82, 205–209.
Choi, M.S., Boise, L.H., Gottschalk, A.R., Quintans, J., Thompson, C.B., and Klaus, GG. (1995). The role of Bel-XL in CD40-mediated rescue from anti-mu-induced apoptosis in WEHI-231 B lymphoma cells. Eur. J. Immunol. 25, 1352–1357.
Colombel, M., Olsson, C.A., Ng, P.Y., and Buttyan, R. (1992). Hormone-regulated apoptosis results from reentry of differentiated prostate cells onto a defective cell cycle. Cancer Res. 52, 4313–319.
Dimri, G.P., Nakanishi, M., Desprez, P.Y., Smith, J.R., and Campisi, J. (1996). Inhibition of E2F activity by the cyclin-dependent protein kinase inhibitor p21 in cells expressing or lacking a functional retinoblastoma protein. Mol. Cell. Biol. 16, 2987–2997.
Dubrez, L., Goldwasser, F., Genne, P., Pommier, Y., and Solary, E. (1995). The role of cell cycle regulation and apoptosis triggering in determining the sensitivity of leukemic cells to topoisomerase I and II inhibitors. Leukemia 9, 1013–1024.
Evan, G.I., Wyllie, A.H., Gilbert, C.S., Littlewood, T.D., Land, H., Brooks, M., Waters, C.M., Penn, L.Z., and Hancock, D.C. (1992). Induction of apoptosis in fibroblasts by c-Myc protein. Cell 69, 119–128.
Ewen, M.E. (1994). The cell cycle and the retinoblastoma protein family. Cancer Metastasis Rev. 13, 45–66.
Ezhevsky, S.A., Toyoshima, H., Hunter, T., and Scott, D.W. (1996). Role of cyclin A and p27 in anti-IgM induced Gl growth arrest of murine B-cell lymphomas. Mol. Biol. Cell 7, 553–564.
Galaktionov, K., Chen, X., and Beach, D. (1996). Cdc25 cell-cycle phosphatase as a target of c-Myc. Nature 382, 511–517.
Garte, S.J. (1993). The c-Myc oncogene in tumor progression. Crit Rev Oncogene 4, 435–449.
Gartel, A.L., Serfas, M.S., and Tyner, A.L. (1996). p21-negative regulator of the cell cycle. Proc. Soc. Exp. Biol. Med. 213, 138–149.
Hale, A.J., Smith, C.A., Sutherland, L.C., Stoneman, V.E., Longthorne, V.L., Culhane, A.C., and Williams, G.T. (1996). Apoptosis: molecular regulation of cell death. Eur. J. Biochem. 236, 1–26.
Harrington, E.A., Bennett, M.R., Fanidi. A., and Evan, GI. (1994). c-Myc-vinduced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J 13, 3286–3295.
Harris, R.A., Hiles, I.D., Page, M.J., and O’Hare, M.J. (1995). The induction of apoptosis in human mammary luminal epithelial cells by expression of activated c-neu and its abrogation by glucocorticoids. Br. J. Cancer 72, 386–392.
Hickman, JA. (1992). Apoptosis induced by anticancer drugs. Cancer Metastasis Rev 11, 121–139.
Hiebert, S.W., Packham, G., Strom, D.K., Haffner, R., Oren, M., Zambetti, G., and Cleveland, J.L. (1995). E2F-1:DP-1 induces p53 and overrides survival factors to trigger apoptosis. Mol. Cell. Biol. 15, 6864–6874.
Higuchi, M., Singh, S., and Aggarwal, B.B. (1995). Characterization of the apoptotic effects of human tumor necrosis factor: development of highly rapid and specific bioassay for human tumor necrosis factor and lym-photoxin using human target cells. J. Immunol. Methods 178, 173–181.
Hinds, P.W., and Weinberg, RA. (1994). Tumor suppressor genes. Curr. Opin. Genet. Dev. 4, 135–141.
Hurlin, P.J., Ayer, D.E., Grandori, C., and Eisenman, R.N. (1994). The Max transcription factor network: involvement of Mad in differentiation and an approach to identification of target genes. Cold Spring Harb. Symp. Quant. Biol. 59, 109–116.
Janicke, R.U., Lee, F.H., and Porter, A.G. (1994). Nuclear c-Myc plays an important role in the cytotoxicity of tumor necrosis factor alpha in tumor cells. Mol. Cell. Biol. 14, 5661–5670.
Johnson, D.G., Schwarz, J.K., Cress, W.D., and Nevins, J.R. (1993). Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365, 349–352.
Klefstrom, J., Vastrik, I., Saksela, E., Valle, J., Eilers, M., and Alitalo, K. (1994). c-Myc induces cellular susceptibility to the cytotoxic action of TNF-alpha. EMBO J. 13, 5442–5450.
Kondo S. (1995). Apoptosis by antitumor agents and other factors in relation to cell cycle checkpoints. J. Radiat. Res. (Tokyo) 36, 56–62.
Larsson, L.G., Pettersson, M., Oberg, F., Nilsson, K., and Luscher, B. (1994). Expression of mad, mxil, max and c-Myc during induced differentiation of hematopoietic cells: opposite regulation of mad and c-Myc. Oncogene 9, 1247–1252.
Lee, W.M. (1989). The Myc family of nuclear proto-oncogenes. Cancer Treat Res 47, 37–71.
Lenardo, M.J. (1991). Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 353, 858–861.
Liebermann, D.A., Hoffman, B., and Steinman, R.A. (1995). Molecular controls of growth arrest and apoptosis: p53-dependent and independent pathways. Oncogene 11, 199–210.
MacLachlan, T.K., Sang, N., and Giordano, A. (1995). Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer. Crit. Rev. Eukaryot. Gene Expr. 5, 127–156.
Martin, K., Trouche, D., Hagemeier, C., and Kouzarides, T. (1995). Regulation of transcription by E2F1/DP1. J. Cell. Sci. Suppl. 19, 91–94.
McConkey, D.J., Zhivotovsky, B., and Orrenius, S. (1996). Apoptosis-molecular mechanisms and biomedical implications. Mol. Aspects Med. 17, 1–110.
Meikrantz, W, and Schlegel, R. (1995). Apoptosis and the cell cycle. J. Cell. Biochem. 58, 160–174.
Miyashita, T., Harigai, M., Hanada, M., and Reed, J.C. (1994). Identification of a p53-dependent negative response element in the Bcl-2 gene. Cancer Res. 54, 3131–3135.
Miyashita, T., and Reed, J.C. (1995). Tumor suppressor p53 is a direct transcriptional activator of the human Bax gene. Cell 80, 293–299.
Montenarh, M. (1992). Biochemical, immunological, and functional aspects of the growth-suppressor/oncoprotein p53. Crit. Rev. Oncog. 3, 233–256.
Murray, M.J., Cunningham, J.M., Parada, L.F., Dautry, F., Lebowitz, P., and Weinberg, R.A. (1983). The HL-60 transforming sequence: a ras oncogene coexisting with altered Myc genes in hematopoietic tumors. Cell 33, 749–757.
Nevins, J.R. (1992). E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258, 424–429.
Pandey, S., and Wang, E. (1995). Cells en route to apoptosis are characterized by the upregulation of c-fos, c-Myc, c-jun, cdc2, and RB phosphorylation, resembling events of early cell-cycle traverse. J. Cell. Biochem. 58, 135–150.
Pica, F., Franzese, O., D’Onofrio, C., Bonmassar, E., Favalli, C., and Garaci E. (1996). Prostaglandin E2 induces apoptosis in resting immature and mature human lymphocytes: a c-Myc-dependent and Bcl-2-independent associated pathway. J. Pharmacol. Exp. Ther. 277, 1793–1800.
Radvanyi, L.G., Shi, Y.F., Mills, G.B., and Miller, R. (1996). Cell cycle progression out of Gl sensitizes primarycultured nontransformed T cells to TCR-mediated apoptosis. Cell. Immunol. 170:260–273.
Rabizadeh, S., Oh, J., Zhong, L.T., Yang, J., Bitler, C.M., Butcher, L.L., and Bredesen, D.E. (1993). Induction of apoptosis by the low-affinity NGF receptor. Science 261, 345–348.
Russell, J.H., White, C.L., Loh, D.L., and Meleedy-Rey, P. (1991). Receptor-stimulated death pathway is opened by antigen in mature T cells. Proc. Natl. Acad. Sci, U.S.A., 88, 2151–2155.
Shan, B., and Lee, W.H. (1994). Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol. Cell. Biol. 14, 8166–8173.
Shi, Y.S, Bissonnette, R.P, Glynn, J.M, Cotter, T.G., Guilbert, J.L., and Green, D.R. (1992). Inhibition of activation-induced apoptosis in T cell hybridomas by antisense oligodeoxynucleotides corresponding to c-Myc. Science 257, 212–214.
Shi, Y.S., Radvanyi, L.G., Mills, G.B., and Miller, R.G. (1995). CD28 ligation inhibits TCR-induced apoptosis during a primary T cell response and prevents induction of T cell hyporesponsiveness. J. Immunol. 156, 1788–1798.
Spencer, C.A., and Groudine, M. (1991). Control of c-Myc regulation in normal and neoplastic cells. Adv. Cancer Res. 56, 1–48.
Tiwari, R.K., Wong, G.Y., Liu, J., Miller, D., and Osborne, M.P. (1991). Augmentation of cytotoxicity using combinations of interferons (types I and II), tumor necrosis factor-alpha, and tamoxifen in MCF-7 cells. Cancer Lett. 61, 45–52.
Ucker, D.S. (1991). Death by suicide: one way to go in mammalian cellular development? New Biol. 3, 103–109.
Vairapandi, M., Balliet, A.G., Fornace, A.J. Jr, Hoffman, B., and Liebermann, D.A. (1996). The differentiation primary response gene MyD118, related to GADD45, encodes for a nuclear protein which interacts with PCNA and p21 WAF1/CIP1. Oncogene 12, 2579–2594.
Wong, G.H. Protective roles of cytokines against radiation: induction of mitochondrial MnSOD. Biochim. Biophys. Acta. 1271, 205-209.
Wu, S., Pena, A., Korcz, A., Soprano, D.R., and Soprano, K.J. (1996). Overexpression of Mxil inhibits the induction of the human ornithine decarboxylase gene by the Myc/Max protein complex. Oncogene 12, 621–629.
Wyllie, A.H., Kerr, J.F.R., and Currie, A.R. (1980). Cell death: The significance of apoptosis. Int. Rev. Cytol. 68, 251–306.
Zola H. (1996). Analysis of receptors for cytokines and growth factors in human disease. Dis. Markers 12, 225–240.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Shi, Y., Mills, G.B., Wang, R. (1997). Mitogenic Cytokines Promote Apoptosis. In: Shi, YB., Shi, Y., Xu, Y., Scott, D.W. (eds) Programmed Cell Death. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0072-2_12
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0072-2_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0074-6
Online ISBN: 978-1-4899-0072-2
eBook Packages: Springer Book Archive